What’s Top of Mind for Ambulatory Infusion Center (AIC) Leaders Right Now

Key Takeaways
  • Time to therapy is a critical performance metric for AIC leaders.
  • Payer changes require operational action.
  • Better visibility supports better decisions.
  • Growth exposes operational weaknesses.
  • AI works best when paired with expertise.

Ambulatory infusion centers (AICs) are entering a new phase of growth. Demand is rising as more care moves into lower-cost settings and organizations consider expansion.

The opportunity is significant, but sustainable growth depends on the right operating model. AIC leaders must improve patient access and financial performance while building the capacity to scale without adding unnecessary complexity.

These themes came up repeatedly in our recent conversations at NICA. Leaders are focused on getting patients to treatment faster, staying ahead of payer changes and making sure their organizations have the visibility and infrastructure needed to grow.


Time to Therapy Is a Critical Performance Metric

Patient access is about more than geography. It also depends on how quickly a patient can move from referral to treatment.

Delays often begin with incomplete referrals, missing documentation or slow authorization follow-up. When information moves through manual handoffs, patients may wait longer for treatment while staff spend more time tracking down details and correcting errors. The result can be scheduling gaps, additional rework and lost revenue.

AIC leaders need a clear view of where referrals are slowing down and how long each step is taking. More consistent intake and authorization workflows can help reduce delays, improve referral conversion and move patients to therapy sooner.

Payer Changes Require Operational Action

Payer policies continue to shape where patients receive infusion therapy and how providers are reimbursed.

Changes to prior authorization rules or site-of-care requirements can affect both access and financial sustainability. AIC leaders need to understand how those policies are influencing referral patterns and reimbursement so they can adjust before problems appear in denials or declining margins.

Organizations that respond early are better positioned to protect access and maintain stronger financial performance.

Better Visibility Supports Better Decisions

Revenue cycle data should do more than explain what happened last month. It should help leaders decide what needs attention now.

When leaders can see where A/R is aging, where work is stalled and which payers are driving delays, they can respond more quickly. The most useful dashboards connect financial performance with the operational factors behind it, helping teams focus resources where they will have the greatest impact.

The goal is not more reporting. It is better visibility into what is slowing performance and what action should come next.

Growth Exposes Operational Weaknesses

Expansion remains one of the largest opportunities in the infusion market. More centers and higher referral volume can create meaningful growth, but they can also expose weaknesses that were manageable at a smaller scale.

Organizations positioned to scale build the operational foundation first. They establish consistent workflows and accountability while creating enough flexibility to support changing volume and payer requirements.

The real question is not whether an AIC can handle more referrals today. It is whether it can absorb continued growth without compromising access or financial performance.

AI Works Best When Paired With Expertise

AI and automation can improve consistency and reduce repetitive work, but technology alone cannot solve unclear processes or limited staffing.

The strongest operating models pair technology with people who understand infusion reimbursement and the day-to-day realities of the revenue cycle.

Prochant works as an extension of infusion organizations, bringing specialized infusion expertise and scalable support across the revenue cycle. Metric dashboards give leaders visibility into the KPIs that matter most so they can identify bottlenecks, understand performance trends and act sooner.

This combination of expertise and visibility helps AICs strengthen execution while maintaining accountability and control. The objective is not simply to outsource work. It is to build a stronger operating model that can support higher referral volume and sustainable growth.

Preparing for the Next Phase of Growth

The priorities facing AIC leaders are closely connected. Faster referral processing supports time to therapy, better visibility leads to stronger decisions and scalable workflows help organizations grow without placing more strain on internal teams.

AIC leaders who bring these elements together will be better positioned to expand access and adapt as the market continues to change.

If you missed us at NICA, schedule a conversation with the Prochant team to discuss the priorities shaping your AIC’s next phase of growth.

Frequently Asked Questions

What are the top priorities for ambulatory infusion center (AIC) leaders today?

AIC leaders are focused on improving time to therapy, responding to payer changes, gaining better visibility into operational and financial performance, building scalable workflows and using AI and automation alongside specialized infusion expertise.

Why is time to therapy an important metric for AICs?

Time to therapy measures how quickly a patient can move from referral to treatment. Delays caused by incomplete referrals, missing documentation or slow authorization follow-up can affect patient access, create scheduling gaps, increase rework and delay revenue.

How do payer changes affect ambulatory infusion centers?

Changes to prior authorization requirements, site-of-care policies and reimbursement rules can influence where patients receive infusion therapy, how quickly they can access treatment and how AICs are reimbursed. Monitoring these changes helps organizations adjust workflows before issues appear in denials or declining margins.

How can AIC leaders use revenue cycle data to improve performance?

Revenue cycle data can help AIC leaders identify where A/R is aging, where work is stalled and which payers are driving delays. Dashboards that connect financial performance with operational factors can help teams identify bottlenecks, prioritize resources and take action sooner.

How can AI and specialized expertise help AICs scale?

AI and automation can improve consistency, reduce repetitive work and provide better visibility into performance, while specialized infusion expertise helps organizations navigate reimbursement complexity and day-to-day revenue cycle challenges. Together, they can support stronger execution, higher referral volume and more sustainable growth.